Skip to content

Intervention Evaluation Study on the Development and Application of a Decision Support System for Type 2 Diabetes Diagnosis and Treatment

Intervention Evaluation Study on the Development and Application of a Decision Support System for Type 2 Diabetes Diagnosis and Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115272
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes(T2DM) . Meets the diagnostic criteria for T2DM as outlined in the Chinese Diabetes Prevention and Treatment Guidelines: exhibits typical diabetic symptoms (excessive thirst, frequent urination, increased appetite, etc.), along with fasting venous plasma glucose =7.0 mmol/L or glycated hemoglobin (HbA1c) =6.5%.

Interventions

Control group:Routine diagnosis and treatment mode
Intervention group:Medical staff used the CDSS for decision support. Prior to the intervention, staff received standardized training. During the early phase of the intervention (months 1–3), on-site t

Sponsors

Shandong Provincial Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Participants diagnosed with T2DM at enrollment, as defined by the latest diabetes guidelines, including typical diabetic symptoms plus fasting venous plasma glucose >= 7.0 mmol/L or HbA1c >= 6.5%. 2. Age between 18 and 80 years. 3. T2DM patients enrolled in community-based management and continuously residing in the study community. 4. Informed consent obtained.

Exclusion criteria

Exclusion criteria: 1.Patients with mental disorders; 2.Terminally ill patients; 3.Individuals unwilling to accept intervention from an auxiliary decision-making system or those for whom follow-up is anticipated to be unfeasible; 4.Individuals who have participated in other clinical trials; 5.Those who are pregnant or planning to become pregnant; 6.The doctor determined that others were unsuitable for participation in this trial;

Design outcomes

Primary

MeasureTime frame
Glycated Hemoglobin Compliance Rate;

Secondary

MeasureTime frame
Fasting Venous Plasma Glucose Compliance Rate;Patient medication adherence;

Countries

China

Contacts

Public ContactSong Chao

Shandong Provincial Third Hospital

34427851@qq.com+86 18615285182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026